Schmerztherapie bei diabetischer Polyneuropathie

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 48, 1997, Pages 1500-1506

  Luft, D ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Universitätsklinik Und Poliklinik Otfried   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIPHENHYDRAMINE; FLUOXETINE; IMIPRAMINE; LIDOCAINE; MEXILETINE; MIANSERIN; PAROXETINE; PHENYTOIN; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

DIABETIC NEUROPATHY; HUMAN; PAIN; PHYSIOTHERAPY; REVIEW;

ANALGESICS; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS; CONTROLLED CLINICAL TRIALS; DEPRESSION; DIABETIC NEUROPATHIES; HUMANS; MULTICENTER STUDIES; PAIN; PHYSICAL THERAPY MODALITIES; RETROSPECTIVE STUDIES;

EID: 0031466703     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047792     Document Type: Article

References (78)

1. Anbar, D.: On estimating the difference between two probabilities, with special reference to clinical trials. Biometrics 39 (1983), 257-262.
2. Archer, A. G.. P. J. Watkins, P. K. Thomas, A. K. Sharma, J. Payan: The natural history of acute painful neuropathy in diabetes mellitus. J. Neurol. Neurosurg. Psych. 46 (1983), 491 -499.
3. Belgrade, M. J., 'B. I. Lev: Diabetic neuropathy. Helping patients cope with their pain. Postgrad. Med. 90 (1991), 263-270.
4. Benbow, S. J.. A. W. Chan, D. Bowsher. I. A. MacFarlane, G. Williams: A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Med. 11 (1994), 17-21.
5. Biesbroeck, R.. V. Bril, P. Hollander, U. Kabadi, S. Schwartz, S. P. Singh, W. K. Ward, J. E. Bernstein: A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv. Then 12(1995), 111-120.
6. Bischoff, A.: The natural course of diabetic neuropathy. A follow up. In Cries, F. A., H. J. Freund, F. Rabe, H. Berger (Eds.): Aspects of autonomie neuropathy in diabetes. Hormone Metab. Res. Suppl. 9 (1980), 98-100.
7. Boulton, A.J. M., W. D. Armstrong,]. Scarpello.J. D. Ward: The natural history of painful diabetic neuropathy. A 4-year study. Post-grad. Med.J. 59 (1983), 556-559.
8. Boulton, A. J. M., J. Drury, B. Clarke, J. D. Ward: Continuous subcutaneous insulin infusion in the mangement of painful diabetic neuropathy. Diabetes Care 5 (1982), 386-390.
9. Boulton, A. J. M., S. Levin, L. Comstock: A multicenter trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy. Diabetologia 33 (1990), 430-437.
10. Byas-Smith, M. G., M. B. Max, J. Muir, A. Kingman: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage enriched enrollment design. Pain 60 (1995), 267-274.
11. The Capsaicin Study Group: Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehiclecontrolled study. Arch, intern. Med. 151 (1991), 2225-2229.
12. The Capsaicin Study Group: Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 15 (1992), 159-165.
13. Chad, D. A., N. Aronin, R. Lundstrom, P. McKeon, D. Ross, M. Molitch. H. M. Schipper, G. Stall, E. Dyess, D. Tarsy: Does capsaicin relieve the pain of diabetic neuropathy? Pain 42 (1990), 387-388.
14. Chadda. V. S., M. S. Mathur: Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J. Assoc. Phys. Ind. 26 (1978), 403-406.
15. Cohen, K. L, S. Harris: Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch, intern. Med. 147 (1987), 1442-1444.
16. Cohen, K. L, F. E. Lucibello, M. A. Chomiak: Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy. Diabetes Care 13 (1990), 1074-1077.
17. Dejgard, A., P. Petersen, J. Kastrup: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1 (1988), 9-11.
18. Deyo, R. A., N. E. Walsh, D. C. Martin, L S. Schoenfeld, S. Ramamurthy: A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain. New Engl. J. Med. 322 (1990), 1627-1634.
19. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann. intern. Med. 122 (1995), 561-568.
20. Doucet,J., J. Senant.J. F. Menard.J. Fresel, J. C Schrub: Amelioration de la polynévrite diabétique sous naftidrofuryl. Résultats pré liminaires. Therapie 46 (1991 ), 305-308.
21. Ellenberg, M.: Treatment of diabetic neuropathy with diphenylhydantoin. N. Y. State J. Med. 68 (1968), 2653-2655.
22. Forst, T.. A. Pfützner, H. Ayric, A. Ambrosch, H. Lehnert, E. Küstner: Die transkutane elektrische Nervenstimulation in der Therapie der symptomatischen somatosensorischen diabetischen Polyneuropathie. Diabetes Stoffw. 5 (1996), 203-208.
23. Franklin, G. M., L B. Kahn, J. Baxter. J. A. Marshall, R. F. Hamman: Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Amer.J. Epidemiol. 130 (1990). 633-643.
24. Greene. D. A., M. J. Brown, S. N. Braunstein, S. S. Schwartz, A. K. Asbury, A. I. Winegrad: Comparison of clinical course and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes 30 (1981). 139-147.
25. Harris. M., R. Eastman, C. Cowie: Symptoms of sensory neuropathy in adults with N1DDM in the U.S. population. Diabetes Care 16(1993). 1446-1452.
26. Hoshi, K., Y. Mizushima, S. Kiyokawa, A. Yanagawa: Prostaglandin El incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy. Drugs Exp. Gin. Res. 12 (1986), 681-685.
27. Jamal. G. A., H. Carmichael: The effect of y-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebocontrolled trial. Diabetic Med. 7 (1990). 309-323.
28. James, J. S., J. C. Page: Painful diabetic peripheral neuropathy. A stepwise approach to treatment. J. Amer. Pediatr. Med. Assoc. 84 (1994), 439-447.
29. Kastrup,J., H. R. Angelo, P. Petersen, A. Dejgard.J. Hilsted: Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Brit. Med. J. 292 (1986), 173.
30. Kastrup. J., P. Petersen, A. Dejgard, H. R. Angelo, J. Hilsted: Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy? Pain 28 (1987). 69-75.
31. Koutsikos, D., B. Agroyannism, H. Tzanatos-Exarchou: Biotin for diabetic peripheral neuropathy. Biomed. Pharmacol. 44 (1990), 511-514.
32. Kvinesdal, B., J. Molin, A. Froland, L F. Gram: Imipramine treatment of painful diabetic neuropathy. J. Amer. Med. Ass. 251 (1984), 1727-1730.
33. Ledermann, H., K. D. Wiedey: Behandlung der manifesten diabetischen Polyneuropathie. Therapeutische Wirkung des neurotropen Vitamin-B-Komplexes B,-B6-B12. Therapiewoche 39 (1989), 1445-1449.
34. MacLeod, A. F., A. J. M. Boulton. D. R. Owens, P. van Rooy, J. M. A. van Gerven, S. Macrury, J. H. B. Scarpello, O. Segers, S. R. Heller. E. A. van der Veen, and the North European Tolrestat Study group: A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. Diabet. Metab. 18(1992), 14-20.
35. Maser. R. E., V. K. Nielsen, E. B. Bass, Q. Manjoo. J. S. Dorman, S. F. Kelsey, D. J. Becker, T. J. Orchard: Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12 (1989), 270-275.
36. Maser, R. E., A. R. Steenkiste, J. S. Dorman, V. K. Nielsen, E. B. Bass, Q. Manjoo, A. L Drash, D. J. Becker, L H. Kuller. D. A. Greene, T. J. Orchard: Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38 (1989), 1456-1461.
37. Max. M. B., M. Culnane, S. C. Schafer, R. H. Gracely, D. J. Walther, B. Smoller, R. Dubner: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987), 589-596.
38. Max, M. B.. S. A. Lynch.J. Muir, S. E. Shoaf. B. Smoller. R. Dubner: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New Engl.J. Med. 326 (1992), 1250-1256.
39. Mayne, N.: The short-term prognosis in diabetic neuropathy. Diabetes 17 (1968), 270-273.
40. McCann, V. J., R. E. Davis: Pyridoxine and diabetic neuropathy. A double-blind controlled study. Diabetes Care 6 (1983), 102-103.
41. McQuay, H., D. Carroll, A. R. Jadad, P. U. Wiffen, A. Moore: Anticonvulsant drugs for management of pain: a systematic review. Brit. Med. J. 301 (1995). 1047-1052.
42. Müller-Felber, W.. R. Landgraf, R. Scheuer, S. Wagner, C. D. Reimers, J. Nusser, D. Abendroth, W. D. Illner, W. Land: Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 42 (1993), 1482-1486.
43. Nicolucci, A., F. Carinci, D. Cavalière, N. Scorpiglione, M. Belfiglio, D. Labbrozzi, E. Mari, M. Massi Benedetti, G. Tognoni, A. Liberati, on behalf on the Italian study group for the implementation of the St. Vincent Declaration: A meta-analysis of trials on aldose reductase inhibitors in diabetic neuropathy. Diabetic Med. 13 (1996), 1017-1026.
44. Ocaranza Ochoa, J.. A. Cervantes Amezcua, V. Macias Torres, P. Casillas Ochoa,J. L Ferez Becerra: La carbamazepina en el tratamiento de la neuropatia diabetica. Prensa Med. Mex. 33 (1968), 132-135.
45. O'Hare, J. A., F. Abuaisha, M. Geoghegan: Prevalence and forms of neuropathic morbidity in 800 diabetics. Irish. J. Med. Sci. 163 (1994), 132-135.
46. Pfeifer, M. A., D. R. Ross, J. P. Schräge, D. A. Gelber, M. P. Schumer, G. M. Crain, S. J. Markwell, S. Jung: A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 16 (1993), 1103 -1115.
47. Quatraro. A., A. Minei, N. De Rosa, D. Guigliano: Calcitonin in painful diabetic neuropathy. Lancet 339 (1992), 746-747.
48. Ray, W. A., M. R. Griffin, W. Schaffner, D. K. Baugh, L J. Melton: Psychotropic drug use and the risk for hip fracture. New Engl.J. Med. 306 (1987), 363-369.
49. Rechlin, T., D. Claus, M. Weis: Heart rate analysis in 24 patients treated with 150mg amitriptyline per day. Psychopharmacology 116 (1994), 110-114.
50. Rechlin, T., M. Weis, D. Claus: Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomie function. Pharmacopsychiatry 27 (1994), 124-128.
51. Reichard, P., M. Pihl, U. Rosenqvist, J. Sule: Complications in IDDM are caused by elevated blood glucose level. The Stockholm diabetes intervention study (SDIS) at 10-year follow up. Diabetologia 39 (1996), 1483-1488.
52. Robinson, D., J. Yesavage, J. Tinklenberg: Diabetic neuropathy and possible treatment. J. Amer. Geriatr. Soc. 42 (1994), 570-571.
53. Rull, J. A., R. Quibrera, H. Gonzalez-Millan, 0. Lozano Castaneda: Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): Double blind crossover trial. Diabetologia 5 (1969), 215-218.
54. Sackett, D. L, W. S. Richardson, W. Rosenberg, R. B. Haynes: Evidence-based Medicine. How to practice £teach it. (Churchill Livingstone: New York 1997).
55. Santiago, J. V., P. H. Sönksen, A. J. M. Boulton. A. MacLeod, M. Beg, W. Bochenek, G. J. Graepel. B. Gonen, the Tolrestat Study Group: Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy. Effect on nerve function. J. Diab. Comp. 7(1993), 170-178.
56. Saudek, C. D., S. Werns, M. M. Reidenberg: Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin. Pharmacol. Then 22 (1977), 196-199.
57. Shindo, H., M. Tavvata, K. Aida, T. Onaya: Clinical efficacy of a stable prostacyclin analog, iloprost, in diabetic neuropathy. Prostaglandins 41 (1991). 85-95.
58. Sindrup, S. H.: Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects. Dan. Med. Bull. 41 (1994), 66-78.
59. Sindrup. S. H., F. W. Bach, L F. Gram: Plasma ß-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms. Clin. J. Pain 8 (1992), 145-148.
60. Sindrup, S. H., B. Ejlertsen, A. Froland, E. H. Sindrup. K. Brosen, L F. Gram: Imipramine treatment in diabetic neuropathy. Relief of subjective symptoms without changes in peripheral and autonomie nerve function. Europ. J. Clin. Pharmacol. 37 (1989), 151-153.
61. Sindrup. S. H., L F. Gram. K. Brosen, 0. Eshoj, E. F. Mogensen: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 (1990), 135-144.
62. Sindrup. S. H., L F. Gram, T. Skjold, A. Froland, H. Beck-Nielsen: Concentration-response relationship in imipramine treatment of diabetic neuropathic symptoms. Clin. Pharmacol. Then 47 (1990), 509-515.
63. Sindrup. S. H., L F. Gram, T. Skjold, E. Grodum. K. Brosen, H. BeckNielsen: Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind crossover study. Brit. J. Clin. Pharmacol. 30 (1990). 683 - 691.
64. Sindrup, S. H., C. Tuxen, L F. Gram. E. Grodum, T. Skjold, K. Brosen, H. Beck-Nielsen: Lack of effect of mianserin on the symptoms of diabetic neuropathy. Europ. J. Clin. Pharmacol. 43 (1992). 251-255.
65. Stracke, H.: Die Alpha-Liponsäure in der Therapie der Neuropathie. In: K. Federlin (Hrsg.): Polyneuropathien. (Thieme: Stuttgart 1995).
66. Stracke, H., U. E. Meyer, H. E. Schumacher, K. Federlin: Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 15 (1992), 1550-1555.
67. Tandan. R., G. A. Lewis, G. B. Badger. T. J. Fries: Topical capsaicin in painful diabetic neuropathy. Effect on sensory function. Diabetes Care 15 (1992). 15-18.
68. Turkington, R. W.: Depression masquerading as diabetic neuropathy. J. Amer. med. Ass. 243 (1980), 1147-1150.
69. Walters, D. P., W. Catling. M. A. Mullee, R. D. Hill: The prevalence of diabetic distal sensory neuropathy in an english community. Diabetic. Med. 9 (1992). 349-353.
70. Ward, J. D., W. Armstrong, E. Preston, L Best, B. O'Malley.J. Scarpello: Pain in the diabetic leg. A trial of aspirin and dipyridamole in diabetic neuropathy. Pharmatherapeutica 2 (1981), 642-647.
71. Wilton, T. D.: Tegretol in the treatment of diabetic neuropathy. Sth. Afr. Med.J. 48 (1974), 869-872.
72. Young, R. J., B. F. Clarke: Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabet. Med. 2 (1985), 363-366.
73. Young, R.J., D. J. Ewing, B. F. Clarke: Chronic and remitting painful f diabetic polyneuropathy. Diabetes Care 11 (1988), 34-40.
74. Zeigler, D., S. A. Lynch, J. Muir.J. Benjamin, M. B. Max: Transdermal clonidine versus placebo in painful diabetic neuropathy. Pain 48 (1992). 403-408.
75. Ziegler. D., F. A. Cries: Klinik, Pathogenese und Therapie der diabetischen Neuropathie. Akt. Endokrin. 13(1992), 140-150.
76. Ziegler, D.. F. A. Gries, H. Mühlen, W. Rathmann. M. Spüler, F. Lessmann, and the Diacan Multicenter Study Group: Prevalence and clinical correlates of cardiovascular autonomie and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab. 19(1993), 143-151.
77. Ziegler, D., M. Hanefeld, K.J. Ruhnau, H. P. Meissner, M. Lobisch, K. Schütte, F. A. Gries: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant a-Iipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38(1995), 1425-1433.
78. Zieleniewski, W.: Calcitonin nasal spray for painful diabetic neuropathy. Lancet 336 (1990), 449.